Article Name Europe
The Breakthrough Device Designation is granted to medical technologies that have the potential to provide more effective treatment for life-threatening or irreversibly debilitating conditions
09th April, 2026
Across Philips’ businesses, Dr Peron and her team provide medical leadership in areas including medical safety, medical affairs, health economics and outcomes research, clinical research
03rd April, 2026
The company generated €5.4 million in revenue during the year and strengthened its financial position by raising €50.8 million in equity capital in October
31st March, 2026
The Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion.
30th March, 2026
Philips DeviceGuide uses AI to track and visualise mitral valve repair devices in real time during minimally invasive procedures, supporting treatment
27th March, 2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
25th March, 2026
A key milestone in this journey is DeepHealth’s acquisition of Gleamer, which expands its capabilities in X-ray interpretation and automated reporting
23rd March, 2026
The first wireless ionisation chamber array for particle therapy, PSQA delivers fast, reliable verification for proton and carbon ion treatments, supporting emerging techniques such as FLASH and ARC radiotherapy
23rd March, 2026
The companies aim to ignite the next lab revolution, using AI and this yet unmapped data landscape to enable breakthrough discoveries and unprecedented productivity gains
17th March, 2026
The technology is available on the new MyLabE85 GTS Edition that will be showcased together with the brand new MyLabC30 GTS ultrasound system at the Esaote booth
16th March, 2026
Health systems are under unprecedented pressure, with rapidly growing data volumes stretching clinical capacity and contributing to care delays
11th March, 2026
C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators
10th March, 2026
Sectra's solutions accelerate diagnostics, reduce costs, and ease physician workload - enabling faster and better diagnoses
09th March, 2026
These insights help eye care professionals confidently support patients from their very first contact lens experience through presbyopia
06th March, 2026
The Revello Stent is a self-expanding stent with an ultrathin expanded polytetrafluoroethylene covering, designed to help keep iliac arteries open while conforming to vessel anatomy
05th March, 2026
These tools support radiologists but do not replace any part of the reporting process
05th March, 2026
DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting
05th March, 2026
Designed for high-demand environments, Rembra can support 270 exams per day
04th March, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer